From: The prevalence of thyroid disorders in COVID-19 patients: a systematic review and meta-analysis
Title | 1nd Author (y) [ref] | Yes | No | Unclear | Not applicable | |||
---|---|---|---|---|---|---|---|---|
na/Nb | % | na/Nb | % | na/Nb | % | nc | ||
Cohort | Ahhn J (2021) [1] | 8/11 | 72.7 | 1/11 | 9.1 | - | - | 2 |
Lania A (2020) [17] | 7/11 | 63.6 | 3/11 | 27.2 | - | - | 1 | |
Lui DTW (2021) [14] | 5/11 | 45.4 | 5/11 | 45.4 | - | - | 1 | |
Lui DTW (2021) [18] | 8/11 | 72.7 | 2/11 | 18.1 | - | - | 1 | |
Lui DTW (2021) [12] | 7/11 | 63.6 | 2/11 | 18.1 | - | - | 2 | |
Chinmay (2021) [19] | 4/11 | 36.3 | 5/11 | 45.4 | - | - | 2 | |
Max | 8 | 72.7 | 5 | 45.4 | - | - | - | |
Min | 4 | 36.3 | 2 | 18.1 | - | - | - | |
Median | 7 | 63.6 | 2.5 | 22.6 | - | - | - | |
Cross-sectional | Hashemipour S (2022) [20] | 5/8 | 62.5 | 2/8 | 25 | - | - | 1 |
Dabas (2021) [21] | 6/8 | 75 | 2/8 | 25 | - | - | - | |
Max | 6 | 75 | 2 | 25 | - | - | - | |
Min | 5 | 62.5 | 2 | 25 | - | - | - | |
Median | 5.5 | 68.75 | 2 | 25 | - | - | - |